Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lung Neoplasms × apatorsen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 1 Squamous Cell Lung Cancer 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 171 Cisplatin 104 Pemetrexed 94 Paclitaxel 92 Docetaxel 86 Gemcitabine 79 Radiotherapy 76 Erlotinib Hydrochloride 54 Bevacizumab 47 Etoposide 45 durvalumab 35 pembrolizumab 32 Magnetic Resonance Spectroscopy 26 Specimen Handling 25 Gefitinib 24 Radiosurgery 23 Nivolumab 23 Vinorelbine 22 Irinotecan 22 Topotecan 20 osimertinib 19 Drug Therapy 19 atezolizumab 16 Surgical Procedures, Operative 14 Radiation 13 Neoadjuvant Therapy 13 Cetuximab 13 Filgrastim 12 Celecoxib 12 Taxes 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01829113 2018-06-08

Spruce

SCRI Development Innovations, LLC

Phase 2 Completed

155 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡